Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications.
Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Deepak Shrivastava, MD is a board-certified Hospice Medical Director. In addition, he holds board certifications in Internal Medicine, Sleep Medicine, Pulmonary and Critical Care Medicine and Post-Acute and Long-Term Care. He is an academic and clinical faculty at the Sleep, Critical Care and Pulmonary division. He is a Clinical Professor at the University of California. He is an adjunct Professor of Pharmacy at the University of Pacific, School of Pharmacy. He is the recipient of many academic and service awards including the Medical Director of the Year award (2015) at the American Medical Directors Association. Dr. Shrivastava received his training at the State University of New York, University of California, Davis and Stanford. He is an active researcher with a keen interest in medical education. He is directly involved in health care quality and performance improvement. In addition to his active practice of Pulmonary, Critical Care and Sleep Medicine in an ACGME-accredited teaching program, he has been involved in Medicare Hospice Benefit Program since 1989. He is a member of the National Partnership for Healthcare and Hospice Innovation (NPHI). His areas of interest are clinical nursing and hospice physician education, and performance improvement in hospice care.
Inhaltsangabe
1. Introduction 2. Physiologic changes of terminal illness 3. Fundamentals of deprescribing 4. Deprescribing Statins 5. Deprescribing Benzodiazepines 6. Deprescribing Antipsychotics 7. Deprescribing SSRI and SNRIs 8. Deprescribing Tricyclic Antidepressants 9. Deprescribing Anticholinergic drugs for parkinsonism 10. Deprescribing Anticholinergic drugs for urinary incontinence 11. Deprescribing muscle relaxants 12. Deprescribing long-term Opioids 13. Deprescribing Proton Pump Inhibitors 14. Deprescribing Allopurinol 15. Deprescribing Antihyperglycemics Oral 16. Deprescribing Antihyperglycemics Injectable 17. Deprescribing anti-hypertensives 18. Deprescribing Anticoagulants 19. Deprescribing Cholinesterase inhibitors 20. Deprescribing Glaucoma eye drops 21. Deprescribing Vitamin D and Calcium 22. Deprescribing NSAIDs 23. Deprescribing gabapentin and pregabalin 24. Deprescribing long-acting Beta agonist 25. Deprescribing Vitamins 26. Deprescribing medications in children 27. Deprescribing in Transgender and LGBTQ 28. Cultural competency in deprescribing 29. Chaplain and medical social worker 30. When to restart discontinued medications. 31. Medicolegal aspects of deprescribing
